Repertorization & Remedy Selection Note

Repertorization & Remedy Selection Note

Date/Time: [Encounter date and time] | Author: [Clinician name, credentials] | Patient: [Patient identifiers per policy] | Information Sources: [Patient / caregiver / records / direct observation] | Interpreter: [Language, modality, ID] (Include only if used)

Note Type: Supplemental documentation of homeopathic remedy selection reasoning and monitoring; does not replace the primary clinical assessment and plan.

(If no treatment recommendation is being made, omit Clinical Context and Prescription sections and insert the following statement:) Educational analysis—no prescription issued.

Clinical Context

[Target problem(s) or symptom cluster(s) being addressed]; [Patient-centered treatment goal(s) — specific and measurable when possible]; [Problem acuity: acute / subacute / chronic / recurrent / preventive]; [Red-flag screening outcome: screened negative / present with escalation plan] (Limit to 3–5 lines.)

Homeopathic Case Summary

[Concise synopsis of characteristic features driving remedy selection, distinguishing observed data vs clinical interpretation vs uncertain/conflicting elements] (Omit this section if selection is strictly protocol-based rather than individualized.)

• Generals: [Energy] | [Thermals] | [Sleep] | [Appetite/Thirst] | [Cravings/Aversions] | [Perspiration] | [Weather/season sensitivity] (Mark "Not assessed" for any materially relevant domain not evaluated.)
• Particulars: [Location] | [Sensation/character] | [Modalities: better/worse by] | [Concomitants]
• Mental/Emotional: [Mood/affect] | [Cognition] | [Stress responses] (Include only if used in selection.)
• Etiology/Maintaining causes: [Triggers, recent stressors, exposures, lifestyle factors] (Note if speculative.)
• Data quality limitations: [Poor historian / conflicting sources / language barriers / other] (Include only if materially affecting analysis.)

Selection Method & Symptom Analysis

Primary selection pathway: [Repertorization-based / Keynote–materia medica differential / Clinical–protocol approach / Combination: specify elements]

Key Symptoms Used for Selection

• [Symptom label] — [Verbatim description or standardized phrasing] | Source: [Patient quote / caregiver / clinician observation / record]
  • Modalities: [Better/worse by] (Observed)
  • Concomitants: [Associated features present/absent] (Observed)
  • Characteristic rationale: [Why this is characteristic/peculiar for the case] (Clinical interpretation)
  • Interpretive abstraction: [How verbatim symptom mapped to repertory concept] (Include only if applicable)
• [Additional key symptoms as needed]

Rubrics and Sources

(Include only if repertorization-based.)

• [Repertory name & edition] — Rubric: [Full rubric path] | Grade: [If applicable] | Weighting: [Numeric or relative] | Rationale: [Brief justification]
• [Repeat for each rubric used]
• Relevant domains not assessed: [e.g., thermals, cravings, perspiration — list explicitly rather than leaving ambiguous]

Repertorization Results

(Include only if repertorization was performed.)

• Repertory/analysis method: [Repertory name/edition]; [Total score / elimination / polarity weighting / other method]
• Ranked shortlist (top 5–10):
  • [1) Remedy] — [Score/coverage count] — [Notable gaps]
  • [2) Remedy] — [Score/coverage count] — [Notable gaps]
  • [3) Remedy] — [Score/coverage count] — [Notable gaps]
  • [Additional candidates as indicated]
• Interpretation: [Repertorization generated candidate pool; final choice determined by differential reasoning below.]

Candidate Remedies & Selection Rationale

• [Candidate remedy 1]
  • For: [Supporting features/keynotes with sources]
  • Against: [Mismatches/missing keynotes]
  • Reason not selected: [Concise reason] (Include only if not the final selection)
• [Candidate remedy 2]
  • For: [Supporting features/keynotes with sources]
  • Against: [Mismatches/missing keynotes]
  • Reason not selected: [Concise reason] (Include only if not the final selection)
• [Additional candidates as needed]

Differential reasoning: [2–6 key discriminating features, noting which were confirmatory vs disconfirming and their relative weight]

Final selection statement: [Single sentence tying discriminators to the choice, e.g., "Given X, Y, and Z, and despite A, [Remedy] best matches the prioritized characteristic totality."] (If two remedies remain indistinguishable due to missing data, specify what is missing, plan to obtain it, and rationale for any time-limited trial with explicit stop rules.)

Prescription

• Remedy: [Standardized remedy name]
• Potency scale & potency: [e.g., 30C / 200C / LM6]
• Form/route: [Pellets / tablets / liquid] | [Oral / other]
• Dosing schedule: [Dose amount] [Frequency] [Duration or number of doses]
• Manufacturer/Lot: [Manufacturer, lot number] (Include for higher-risk routes or vulnerable populations)

Potency/form rationale: [Case acuity and desired pace of response]; [Patient sensitivity or history of strong reactions]; [Practical factors: adherence, prior response, availability]; [Risk management considerations] (Label tradition-based reasoning as such; do not present as established pharmacology.)

Administration instructions: [How to take]; [What to do if dose missed]; [Storage]; [Contamination avoidance practices if applicable]

Concurrent therapies: [List conventional medications and other therapies] — Patient advised that conventional medications must not be stopped without discussion with prescribing clinician.

Safety, Consent & Coordination

• Conditions requiring conventional evaluation or urgent care: [Suspected conditions]; [Red-flag triggers and patient instructions for when to seek care]
• Evidence/uncertainty disclosure: Patient understands [nature of modality]; [limitations of evidence]; [homeopathic products are not FDA-approved or regulated as conventional drugs]; [alternatives discussed including no treatment and conventional options]
• Care coordination: [PCP/specialist involvement]; [Consent to share information: yes / no]
• Attestation: Informed consent discussion occurred; patient questions addressed.

Monitoring Plan

• Baseline measures: [Symptom diary / validated scale(s) / objective measures] — Current values: [If available]
• Expected response: [Timeframe for first change]; [Meaningful improvement threshold]; [Concerning worsening threshold]
• Hold/stop rules: [When to pause/stop remedy]; [When to seek urgent care]
• Worsening documentation: [Onset timing relative to dosing]; [Worsening of existing vs new symptoms]; [Severity]; [Action taken]
• Aggravation vs adverse event: [Criteria distinguishing temporary aggravation of existing symptoms from new or disproportionate symptoms requiring intervention]
• Follow-up schedule: [Interval and modality]; [Triggers for earlier follow-up]
• Remedy adjustment logic: [If partial response with stable trajectory]; [If plateau]; [If new disconfirming symptoms]; [If adverse reaction suspected]

(Do not infer modalities, mental symptoms, or characteristic features not explicitly documented. Omit inapplicable fields rather than inserting placeholder text, except note "Not assessed" for materially relevant domains that were not evaluated.)